LOGO
LOGO

Quick Facts

Oversea-Chinese Banking Corporation Q4 Net Profit Improves Despite Drop In Net Interest Income

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News

Oversea-Chinese Banking Corporation Limited (O39.SI,OCBC.SI), a Singaporean banking and financial services provider, on Wednesday reported an increase in net profit for the final quarter of fiscal 2025, helped by higher non-interest income.

For the fourth quarter, the lender reported a net income of S$1.745 billion, or S$1.52 per share, higher than S$1.687 billion, or S$1.47 per share, in the same period last year. This rise in net profit reflects strong non-interest income growth.

Total income was S$3.616 billion, higher than S$3.416 billion a year ago. Net interest income slipped to S$2.296 billion from S$2.455 billion a year ago as asset yields compressed at a faster pace than deposit costs in a decreasing interest rate environment.

Non-interest income moved up to S$1.320 billion from S$961 million in the previous year, helped by strong broad-based growth across fee, trading, and insurance income.

As of December 31, 2025, gross loans stood at S$341.120 billion, higher than S$319.166 billion on December 31, 2024. Deposits were S$428 billion on December 31, 2025, higher than S$391 billion as of December 31, 2024.

For 2025, the Board will pay a final dividend of 42 cents per share and a special dividend of 16 cents per share, bringing the total dividend for the year to 99 cents per share.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - April 27 – May 01, 2026

May 01, 2026 15:54 ET
Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.

Latest Updates on COVID-19